Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 11, 2021
Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian populationChaturbhuj Agrawal, Pankaj Goyal, Amit Agarwal, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 12, 2015
Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, IndiaDinesh Chandra Doval, Anila Sharma, Rupal Sinha, et al.
Plos One|May 15, 2026
Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in IndiaAnindya Mukherjee, Pankaj Goyal, Rupal Tripathi, et al.
South Asian Journal of Cancer|June 16, 2021
Role of Maintenance Gemcitabine in Advanced Carcinoma GallbladderManish Sharma, Vineet Talwar, Udip Maheshwari, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|May 1, 2020
Role of 18F-Flurodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Triple-Negative Breast CancerBina Basnet, Pankaj Goyal, Vivek Mahawar, et al.
Japanese Journal of Clinical Oncology|February 13, 2019
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancerParveen Jain, Dinesh Chandra Doval, Ullas Batra, et al.
Asia-Pacific Journal of Clinical Oncology|September 8, 2025
Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open-Label, Single-Arm, Phase IV StudySudeep Gupta, Manish Singhal, Shona Nag, et al.
Lung India : Official Organ of Indian Chest Society|September 1, 2018
The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancerMoushumi Suryavanshi, Anurag Mehta, Manoj Kumar Panigrahi, et al.
Asia-Pacific Journal of Clinical Oncology|December 15, 2021
Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and IndiaSherene Loi, Christos S Karapetis, Nicole McCarthy, et al.
Cancer Medicine|March 9, 2019
Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patientsManjiri M Bakre, Charusheila Ramkumar, Arun Kumar Attuluri, et al.
Pageof 5